Evidence map›Paper›PMID 33118120›Full record

ArticleCellular oncology (Dordrecht, Netherlands)2021

Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging.

Tong Lu, Tong Qiu, Bin Han, Yuanyong Wang, Xiao Sun, Yi Qin, Ao Liu, Nan Ge, Wenjie Jiao

Abstract read
In one paragraph

Article in Cellular oncology (Dordrecht, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy.International journal of molecular sciences · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Tong Lu *Department of Thoracic Surgery, Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
Tong Qiu *Department of Thoracic Surgery, Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
Bin HanDepartment of Thoracic Surgery, Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
Yuanyong WangDepartment of Thoracic Surgery, Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
Xiao SunDepartment of Thoracic Surgery, Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
Yi QinDepartment of Thoracic Surgery, Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
Ao LiuDepartment of Thoracic Surgery, Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
Nan GeDepartment of Thoracic Surgery, Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
Wenjie JiaoDepartment of Thoracic Surgery, Affiliated Hospital of Qingdao University, Qingdao, 266000, China. jiaowj@qduhospital.cn.
Affiliated Hospital of Qingdao University · CNQingdao University · CN

Funding

Key Technology Research and Development Program of Shandong 2018GSF118119
6 · The paper itself

Abstract

backgroundIn the last decade, a relatively novel, ubiquitous and highly stable subclass of non-coding RNAs, called circular (circ)-RNAs, has increasingly been implicated in cancer development, and several of them have been shown to act as microRNA sponges. As yet, however, the role of circRNAs in lung adenocarcinoma (LUAD) development has largely remained unexplored.

methodsBioinformatics, microarray-based and qRT-PCR expression assays were used to assess circRNA, miRNA and mRNA expression in LUAD patient samples and cell lines. siRNA-mediated silencing was used to assess the effect of circCSNK1G3 on various LUAD-associated characteristics such as proliferation, migration, invasion and tumorigenesis, both in vitro and in vivo. Western blotting, immunohistochemistry, fluorescence in situ hybridization (FISH) and luciferase reporter activity assays were used to characterize relationships between circCSNK1G3, miR-143-3p and HOXA10 in LUAD cells.

resultsBy screening for differentially expressed circRNAs, we found that circCSNK1G3 was aberrantly expressed in primary LUAD tissues and cell lines. An oncogenic role of circCSNK1G3 was deduced from its aberrant expression and associated enhancement of LUAD A549 and H1299 cell proliferation, migration and invasion. We also found that circCSNK1G3 can directly interact with and suppress miR-143-3p expression by serving as a 'miR-143-3p sponge'. In addition, we found that circCSNK1G3 can modulate homeobox (HOX) A10 expression through miR-143-3p signaling and, thereby, affect LUAD tumorigenesis.

conclusionsOur data indicate that circCSNK1G3 can induce HOXA10 expression and, thereby, promote the growth and metastasis of LUAD cells through hsa-miR-143-3p sponging. As such, our data highlight the targetability of the circCSNK1G3/miR-143-3p/HOXA10 signaling axis in patients with LUAD. Graphical abstract.

Indexed as

Signal TransductionAdenocarcinoma of LungAnimalsBase SequenceCell Line, TumorCell MovementCell ProliferationDown-RegulationFemaleGene Expression Regulation, NeoplasticGene SilencingHomeobox A10 ProteinsHumansLung NeoplasmsMaleMiceHomeobox A10 ProteinsHOXA10 protein, humanMicroRNAsMIRN143 microRNA, humanRNA, CircularcircCSNK1G3Circular RNAHOXA10LUADmiRNA-143-3p

Identifiers

PMID33118120
PMCPMC12980762
OpenAlexW3096882437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.